Development Level

Tbio 7,820 | 10,625
Tdark 3,204 | 7,003
Tchem 1,389 | 1,890
Tclin 354 | 602

Collection

Kinase: IDG Consortium (Targets) 88 | 125
GPCR: IDG Consortium (Targets) 33 | 127
Ion Channel: IDG Consortium (Targets) 33 | 102
Kinase: IDG Consortium (Complete/Control) 29 | 37
GPCR: IDG Consortium (Complete/Control) 14 | 26

IMPC Phenotype

preweaning lethality, complete... 577 | 633
preweaning lethality, incomple... 209 | 260
abnormal behavior 182 | 226
embryonic lethality prior to t... 177 | 187
decreased lean body mass 160 | 195
decreased total body fat amoun... 154 | 186
decreased body weight 147 | 174
embryonic lethality prior to o... 146 | 148
decreased bone mineral content 122 | 157
increased circulating alkaline... 104 | 119
decreased bone mineral density 100 | 126
abnormal embryo size 97 | 112
increased or absent threshold ... 96 | 128
abnormal bone structure 95 | 131
decreased circulating glucose ... 93 | 121
decreased grip strength 91 | 123
decreased body length 89 | 108
abnormal retina morphology 83 | 100
increased mean corpuscular hem... 83 | 93
enlarged heart 80 | 111
hyperactivity 80 | 108
increased lean body mass 79 | 107
increased mean corpuscular vol... 79 | 91
increased bone mineral content 78 | 92
hypoactivity 70 | 89
decreased circulating choleste... 69 | 85
short tibia 69 | 82
decreased circulating serum al... 66 | 79
increased grip strength 66 | 83
decreased circulating triglyce... 65 | 83
decreased circulating HDL chol... 64 | 77
abnormal lens morphology 58 | 73
prenatal lethality prior to he... 58 | 64
increased fasted circulating g... 56 | 68
decreased lumbar vertebrae num... 53 | 62
increased sacral vertebrae num... 51 | 62
abnormal retinal pigmentation 50 | 61
decreased circulating insulin ... 50 | 75
increased circulating sodium l... 50 | 71
decreased rib number 48 | 59
abnormal sleep behavior 46 | 63
decreased leukocyte cell numbe... 46 | 54
abnormal bone mineralization 45 | 55
abnormal coat-hair pigmentatio... 45 | 54
decreased hemoglobin content 45 | 53
increased bone mineral density 45 | 52
male infertility 45 | 62
decreased mean corpuscular vol... 44 | 50
increased circulating HDL chol... 44 | 63
increased circulating choleste... 42 | 53
decreased erythrocyte cell num... 40 | 43
decreased prepulse inhibition 40 | 52
impaired glucose tolerance 40 | 52
increased total body fat amoun... 40 | 57
decreased circulating alanine ... 39 | 53
increased exploration in new e... 39 | 56
abnormal gait 38 | 51
decreased circulating total pr... 38 | 41
thrombocytopenia 38 | 46
decreased caudal vertebrae num... 37 | 49
decreased startle reflex 37 | 48
decreased fasted circulating g... 36 | 49
improved glucose tolerance 36 | 56
increased blood urea nitrogen ... 36 | 44
abnormal behavioral response t... 35 | 52
increased body weight 34 | 42
decreased circulating free fat... 33 | 39
decreased heart weight 33 | 44
increased hemoglobin content 33 | 45
abnormal heart morphology 32 | 51
abnormal seminal vesicle morph... 32 | 47
decreased circulating LDL chol... 32 | 37
abnormal eye morphology 31 | 38
abnormal neural tube closure 31 | 37
decreased eosinophil cell numb... 31 | 41
increased leukocyte cell numbe... 31 | 37
increased rib number 31 | 41
decreased neutrophil cell numb... 30 | 37
increased hematocrit 30 | 36
decreased circulating alkaline... 29 | 41
decreased circulating fructosa... 29 | 31
decreased mean corpuscular hem... 29 | 34
increased circulating chloride... 29 | 43
abnormal cranium morphology 28 | 32
decreased T cell number 28 | 31
decreased circulating calcium ... 28 | 33
small testis 28 | 37
decreased circulating creatini... 27 | 31
embryonic growth retardation 27 | 28
increased startle reflex 27 | 38
abnormal spleen morphology 26 | 36
cardiovascular system phenotyp... 26 | 35
tremors 26 | 34
increased circulating potassiu... 25 | 31
increased heart weight 25 | 37
decreased blood urea nitrogen ... 24 | 31
decreased circulating chloride... 24 | 32
increased circulating iron lev... 24 | 25
decreased circulating aspartat... 23 | 27
female infertility 23 | 34

Disease

ovarian cancer 7,284 | 8,491
osteosarcoma 6,580 | 7,933
medulloblastoma, large-cell 4,814 | 6,234
psoriasis 4,531 | 6,685
glioblastoma 4,432 | 5,572
lung cancer 3,855 | 4,473
atypical teratoid / rhabdoid tumor 3,379 | 4,369
intraductal papillary-mucinous neoplasm (IPMN) 2,761 | 3,289
malignant mesothelioma 2,675 | 3,163
Breast cancer 2,554 | 3,098
invasive ductal carcinoma 2,520 | 2,950
intraductal papillary-mucinous carcinoma (IPMC) 2,490 | 2,988
intraductal papillary-mucinous adenoma (IPMA) 2,418 | 2,956
primitive neuroectodermal tumor 2,296 | 3,031
non-small cell lung cancer 2,275 | 2,798
pilocytic astrocytoma 2,217 | 3,086
oligodendroglioma 2,110 | 2,849
pediatric high grade glioma 2,100 | 2,712
lung adenocarcinoma 2,080 | 2,714
lung carcinoma 2,059 | 2,844
ependymoma 1,983 | 2,514
pancreatic cancer 1,860 | 2,300
subependymal giant cell astrocytoma 1,834 | 2,287
group 3 medulloblastoma 1,815 | 2,254
Cancer 1,790 | 2,346
interstitial cystitis 1,754 | 2,299
ulcerative colitis 1,736 | 2,087
astrocytic glioma 1,687 | 2,241
Pick disease 1,563 | 1,893
adult high grade glioma 1,555 | 2,148
pancreatic ductal adenocarcinoma liver metastasis 1,547 | 1,795
group 4 medulloblastoma 1,537 | 1,875
pituitary cancer 1,425 | 1,972
ductal carcinoma in situ 1,410 | 1,745
tuberculosis 1,392 | 1,563
Carcinoma 1,378 | 2,147
breast carcinoma 1,340 | 1,614
Multiple myeloma 1,290 | 1,327
cystic fibrosis 1,264 | 1,670
astrocytoma 1,249 | 1,493
adrenocortical carcinoma 1,235 | 1,427
colon cancer 1,167 | 1,475
medulloblastoma 1,146 | 1,524
primary pancreatic ductal adenocarcinoma 1,128 | 1,271
sonic hedgehog group medulloblastoma 1,122 | 1,482
juvenile dermatomyositis 1,117 | 1,189
diabetes mellitus 1,099 | 1,663
posterior fossa group A ependymoma 1,084 | 1,511
acute quadriplegic myopathy 1,067 | 1,157
posterior fossa group B ependymoma 1,047 | 1,530
Rheumatoid Arthritis 1,002 | 1,170
dermatomyositis 898 | 966
cutaneous lupus erythematosus 859 | 1,056
spina bifida 835 | 1,064
atypical teratoid/rhabdoid tumor 826 | 1,095
nasopharyngeal carcinoma 750 | 1,056
Waldenstrons macroglobulinemia 748 | 764
primary Sjogren syndrome 745 | 788
acute myeloid leukemia 731 | 785
active Crohn's disease 726 | 918
gastric carcinoma 706 | 832
Atopic dermatitis 685 | 944
tuberculosis and treatment for 6 months 663 | 686
non primary Sjogren syndrome sicca 656 | 840
progressive supranuclear palsy 585 | 674
aldosterone-producing adenoma 572 | 664
esophageal adenocarcinoma 572 | 737
Duchenne muscular dystrophy 540 | 602
hepatocellular carcinoma 512 | 550
pancreatic carcinoma 512 | 567
Alzheimer's disease 480 | 644
autosomal dominant Emery-Dreifuss muscular dystrophy 457 | 499
Down syndrome 451 | 548
Intellectual disability 451 | 573
IGA Glomerulonephritis 424 | 454
Obesity 414 | 616
fibroadenoma 413 | 557
gastric cancer 402 | 436
Endometriosis 396 | 535
mucosa-associated lymphoid tissue lymphoma 390 | 480
Prostatic Neoplasms 365 | 471
Amyotrophic Lateral Sclerosis 363 | 432
Multiple Sclerosis 349 | 498
active ulcerative colitis 343 | 477
Mammary Neoplasms 336 | 410
chronic rhinosinusitis 334 | 512
inflammatory breast cancer 324 | 404
sarcoidosis 312 | 368
Neurodegenerative disease 309 | 383
Schizophrenia 309 | 503
tuberculosis and treatment for 3 months 304 | 327
hereditary spastic paraplegia 295 | 313
non-small cell lung carcinoma 268 | 413
glioblastoma multiforme 262 | 347
Polycystic Ovary Syndrome 261 | 334
Kidney disease 258 | 397
Parkinson's disease 250 | 364
interstitial lung disease 249 | 292
Crohn's disease 245 | 304
urothelial carcinoma 237 | 318

Tissue

Blood and immune system 12,767 | 17,994
Digestive Tract 12,767 | 18,472
Endocrine System 12,764 | 18,511
Female tissues 12,764 | 18,646
Nervous System 12,761 | 18,560
Skin and soft tissues 12,761 | 18,114
Urinary Tract 12,761 | 18,443
Liver and Pancreas 12,759 | 18,135
Respiratory system 12,752 | 17,483
Male tissues 12,750 | 17,968
Cardiovascular System 12,745 | 17,957

Target Family

Non-IDG 7,364 | 11,969
Enzyme 3,129 | 4,146
Transcription Factor 962 | 1,400
Kinase 506 | 634
Transporter 282 | 473
Epigenetic 210 | 242
GPCR 141 | 408
Ion Channel 109 | 341
TF/Epigenetic 32 | 38
Nuclear Receptor 31 | 48
oGPCR 1 | 421

HPA RNA Tissue

lymph node 12,767 | 12,767
testis 14,882 | 14,882
gallbladder 13,733 | 13,733
fallopian tube 13,708 | 13,708
lung 13,653 | 13,653
prostate 13,628 | 13,628
cerebral cortex 13,579 | 13,579
colon 13,523 | 13,523
urinary bladder 13,516 | 13,516
stomach 13,507 | 13,507
small intestine 13,471 | 13,471
appendix 13,437 | 13,437
endometrium 13,367 | 13,367
rectum 13,362 | 13,362
esophagus 13,354 | 13,354
kidney 13,341 | 13,341
adrenal gland 13,296 | 13,296
duodenum 13,296 | 13,296
smooth muscle 13,192 | 13,192
tonsil 13,066 | 13,066
placenta 13,010 | 13,010
spleen 12,999 | 12,999
adipose tissue 12,955 | 12,955
skin 12,911 | 12,911
salivary gland 12,839 | 12,839
thyroid gland 12,836 | 12,836
heart muscle 12,601 | 12,601
ovary 12,538 | 12,538
liver 12,082 | 12,082
pancreas 11,994 | 11,994
bone marrow 11,255 | 11,255
skeletal muscle 11,029 | 11,029

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Dual specificity protein phosphatase 1 DUSP1 Tchem Enzyme -2.86495 767.9 361
Thyroid adenoma-associated protein THADA Tbio Non-IDG -1.50722 29.2 46
F-box/LRR-repeat protein 3 FBXL3 Tbio Non-IDG -0.94799 9.59 158
Epithelial membrane protein 2 EMP2 Tbio Non-IDG -2.29593 203.1 88
Myeloma-overexpressed gene 2 protein COPS9 Tdark Non-IDG 0.21 0.67 12
Zinc finger protein Aiolos IKZF3 Tbio Transcription Factor -1.78743 55.0 277
Zinc finger protein 215 ZNF215 Tdark Transcription Factor -0.47111 3.15 74
Epithelial membrane protein 3 EMP3 Tbio Non-IDG -1.64647 44.8 131
Meckel syndrome type 1 protein MKS1 Tbio Non-IDG -1.29669 19.6 50
F-box/WD repeat-containing protein 2 FBXW2 Tbio Non-IDG -1.99707 87.2 90